Learn More
Invitrogen™ HGAL Monoclonal Antibody (1H1-A7), eBioscience™, Invitrogen™

Mouse Monoclonal Antibody
£156.00 - £386.00
Specifications
| Antigen | HGAL |
|---|---|
| Clone | 1H1-A7 |
| Concentration | 0.5 mg/mL |
| Applications | ELISA, Immunohistochemistry (Paraffin), Immunoprecipitation, Western Blot |
| Classification | Monoclonal |
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|
15507646
|
Invitrogen™
14-9758-80 |
25 μg |
£156.00
25µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
15517646
![]() |
Invitrogen™
14-9758-82 |
100 μg |
£386.00
100µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
Description
GCET2 is a protein which may function in signal transduction pathways and whose expression is elevated in germinal cell lymphomas. It contains a putative PDZ-interacting domain, an immunoreceptor tyrosine-based activation motif (ITAM), and two putative SH2 binding sites. In B cells, its expression is specifically induced by interleukin-4.This gene encodes a protein which may function in signal transduction pathways and whose expression is elevated in germinal cell lymphomas. It contains a putative PDZ-interacting domain, an immunoreceptor tyrosine-based activation motif (ITAM), and two putative SH2 binding sites. In B cells, its expression is specifically induced by interleukin-4. Alternative splicing results in multiple transcript variants encoding different isoforms.
GCET2 is a protein which may function in signal transduction pathways and whose expression is elevated in germinal cell lymphomas. It contains a putative PDZ-interacting domain, an immunoreceptor tyrosine-based activation motif (ITAM), and two putative SH2 binding sites. In B cells, its expression is specifically induced by interleukin-4.This gene encodes a protein which may function in signal transduction pathways and whose expression is elevated in germinal cell lymphomas. It contains a putative PDZ-interacting domain, an immunoreceptor tyrosine-based activation motif (ITAM), and two putative SH2 binding sites. In B cells, its expression is specifically induced by interleukin-4. Alternative splicing results in multiple transcript variants encoding different isoforms.Specifications
| HGAL | |
| 0.5 mg/mL | |
| Monoclonal | |
| Liquid | |
| RUO | |
| PBS with 0.09% sodium azide; pH 7.2 | |
| GAL; GCAT2; Gcet; GCET2; GCET2 germinal center expressed transcript 2; GCSAM; Germinal center associated lymphoma (hGAL); germinal center associated signaling and motility; germinal center associated, signaling and motility; germinal center B-cell-expressed transcript 2 protein; germinal center expressed transcript 2; germinal center-associated lymphoma protein; Germinal center-associated signaling and motility protein; germinal center-associated, signaling and motility; HGAL; human germinal center-associated lymphoma; M17; M17-L; MGC40441 | |
| GCSAM | |
| Primary | |
| 4°C | |
| GCSAM |
| 1H1-A7 | |
| ELISA, Immunohistochemistry (Paraffin), Immunoprecipitation, Western Blot | |
| Unconjugated | |
| Mouse | |
| Human, Mouse | |
| Q6RFH4, Q8N6F7 | |
| 14525, 257144 | |
| IgG2a κ | |
| Affinity chromatography | |
| Antibody |
For Research Use Only.
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.